CDK7 inhibition is a novel therapeutic strategy against GBM both in vitro and in vivo

BACKGROUND: Glioblastoma multiforme (GBM) remains to be one of the top lethal cancer types for adult to date. Current GBM therapies suffer greatly from the highly heterogeneous and adaptable nature of GBM cells, indicating an urgent need of alternative therapeutic options. In this study, we focused...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Manag Res
Main Authors: Meng, Wei, Wang, Jiajia, Wang, Baocheng, Liu, Fang, Li, Meng, Zhao, Yang, Zhang, Chenran, Li, Qifeng, Chen, Juxiang, Zhang, Liye, Tang, Yujie, Ma, Jie
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2018
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6245350/
https://ncbi.nlm.nih.gov/pubmed/30532595
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S183696
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados